Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-22-000008

Options or other derivatives

  • Chief Development Officer acquired 256,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Picchio Gaston · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +256,500 $2.81 $720,765 256,500 D
Loading xslF345X03/wf-form4_164271923431244.xml…